Rebecca L Hansford, Hélène Ouellette-Kuntz, Rebecca Griffiths, Julie Hallet, Kathleen Decker, David E Dawe, Mark Kristjanson, Virginie Cobigo, Shahin Shooshtari, Morgan Stirling, Christine Kelly, Marni Brownell, Donna Turner, Alyson Mahar
{"title":"智力或发育障碍人士的乳腺癌(女性)、结直肠癌和肺癌存活率:基于人群的回顾性队列研究。","authors":"Rebecca L Hansford, Hélène Ouellette-Kuntz, Rebecca Griffiths, Julie Hallet, Kathleen Decker, David E Dawe, Mark Kristjanson, Virginie Cobigo, Shahin Shooshtari, Morgan Stirling, Christine Kelly, Marni Brownell, Donna Turner, Alyson Mahar","doi":"10.17269/s41997-023-00844-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Cancer is a leading cause of death among people living with intellectual or developmental disabilities (IDD). There is little empirical evidence documenting survival or comparing outcomes to those without IDD. This study investigated the association between IDD and cancer survival among adults with breast (female), colorectal, or lung cancer.</p><p><strong>Methods: </strong>A population-based retrospective cohort study was conducted in Ontario, Canada, with routinely collected data. Patients with breast, colorectal, or lung cancer were included (2007‒2019). IDD status before cancer was determined using an established administrative data algorithm. The outcomes of interest included death from any cause and death from cancer. Cox proportional hazards models and competing events analyses using multivariable cause-specific hazards regression were completed. Analyses were stratified by cancer type. Interactions with age, sex, and stage at diagnosis, as well as sensitivity analyses, were completed.</p><p><strong>Results: </strong>The final cohorts included 123,695 breast, 98,809 colorectal, and 116,232 lung cancer patients. Individuals with IDD experienced significantly worse survival than those without IDD. The adjusted hazard ratios of all-cause death were 2.74 (95% CI 2.41‒3.12), 2.42 (95% CI 2.18‒2.68), and 1.49 (95% CI 1.34‒1.66) times higher for breast, colorectal, and lung cancer patients with IDD relative to those without. These findings were consistent for cancer-specific deaths. With few exceptions, worse survival for people with IDD persisted regardless of stage at diagnosis.</p><p><strong>Conclusion: </strong>People with IDD experienced worse cancer survival than those without IDD. Identifying and intervening on the factors and structures responsible for survival disparities is imperative.</p>","PeriodicalId":51407,"journal":{"name":"Canadian Journal of Public Health-Revue Canadienne De Sante Publique","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11027730/pdf/","citationCount":"0","resultStr":"{\"title\":\"Breast (female), colorectal, and lung cancer survival in people with intellectual or developmental disabilities: A population-based retrospective cohort study.\",\"authors\":\"Rebecca L Hansford, Hélène Ouellette-Kuntz, Rebecca Griffiths, Julie Hallet, Kathleen Decker, David E Dawe, Mark Kristjanson, Virginie Cobigo, Shahin Shooshtari, Morgan Stirling, Christine Kelly, Marni Brownell, Donna Turner, Alyson Mahar\",\"doi\":\"10.17269/s41997-023-00844-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Cancer is a leading cause of death among people living with intellectual or developmental disabilities (IDD). There is little empirical evidence documenting survival or comparing outcomes to those without IDD. This study investigated the association between IDD and cancer survival among adults with breast (female), colorectal, or lung cancer.</p><p><strong>Methods: </strong>A population-based retrospective cohort study was conducted in Ontario, Canada, with routinely collected data. Patients with breast, colorectal, or lung cancer were included (2007‒2019). IDD status before cancer was determined using an established administrative data algorithm. The outcomes of interest included death from any cause and death from cancer. Cox proportional hazards models and competing events analyses using multivariable cause-specific hazards regression were completed. Analyses were stratified by cancer type. Interactions with age, sex, and stage at diagnosis, as well as sensitivity analyses, were completed.</p><p><strong>Results: </strong>The final cohorts included 123,695 breast, 98,809 colorectal, and 116,232 lung cancer patients. Individuals with IDD experienced significantly worse survival than those without IDD. The adjusted hazard ratios of all-cause death were 2.74 (95% CI 2.41‒3.12), 2.42 (95% CI 2.18‒2.68), and 1.49 (95% CI 1.34‒1.66) times higher for breast, colorectal, and lung cancer patients with IDD relative to those without. These findings were consistent for cancer-specific deaths. With few exceptions, worse survival for people with IDD persisted regardless of stage at diagnosis.</p><p><strong>Conclusion: </strong>People with IDD experienced worse cancer survival than those without IDD. Identifying and intervening on the factors and structures responsible for survival disparities is imperative.</p>\",\"PeriodicalId\":51407,\"journal\":{\"name\":\"Canadian Journal of Public Health-Revue Canadienne De Sante Publique\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11027730/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Journal of Public Health-Revue Canadienne De Sante Publique\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.17269/s41997-023-00844-8\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Public Health-Revue Canadienne De Sante Publique","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17269/s41997-023-00844-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
摘要
目标:癌症是智力或发育障碍(IDD)患者的主要死因。目前几乎没有实证证据可以证明其存活率或与非 IDD 患者的结果进行比较。本研究调查了患有乳腺癌(女性)、结肠直肠癌或肺癌的成年人中 IDD 与癌症存活率之间的关系:方法:在加拿大安大略省进行了一项基于人群的回顾性队列研究,研究使用了常规收集的数据。研究纳入了乳腺癌、结肠直肠癌或肺癌患者(2007-2019 年)。癌症前的 IDD 状态是通过既定的行政数据算法确定的。相关结果包括任何原因导致的死亡和癌症导致的死亡。利用多变量病因特异性危险回归完成了 Cox 比例危险模型和竞争事件分析。分析按癌症类型进行分层。还完成了与年龄、性别和诊断分期的交互作用以及敏感性分析:最终的队列包括 123,695 名乳腺癌患者、98,809 名结直肠癌患者和 116,232 名肺癌患者。IDD患者的生存率明显低于非IDD患者。患有 IDD 的乳腺癌、结直肠癌和肺癌患者的全因死亡调整危险比分别为 2.74(95% CI 2.41-3.12)、2.42(95% CI 2.18-2.68)和 1.49(95% CI 1.34-1.66)倍。这些发现与癌症特异性死亡的情况一致。除少数例外情况外,无论诊断时处于哪个阶段,IDD患者的生存率都较低:结论:IDD患者的癌症生存率低于非IDD患者。当务之急是找出并干预造成生存率差异的因素和结构。
Breast (female), colorectal, and lung cancer survival in people with intellectual or developmental disabilities: A population-based retrospective cohort study.
Objectives: Cancer is a leading cause of death among people living with intellectual or developmental disabilities (IDD). There is little empirical evidence documenting survival or comparing outcomes to those without IDD. This study investigated the association between IDD and cancer survival among adults with breast (female), colorectal, or lung cancer.
Methods: A population-based retrospective cohort study was conducted in Ontario, Canada, with routinely collected data. Patients with breast, colorectal, or lung cancer were included (2007‒2019). IDD status before cancer was determined using an established administrative data algorithm. The outcomes of interest included death from any cause and death from cancer. Cox proportional hazards models and competing events analyses using multivariable cause-specific hazards regression were completed. Analyses were stratified by cancer type. Interactions with age, sex, and stage at diagnosis, as well as sensitivity analyses, were completed.
Results: The final cohorts included 123,695 breast, 98,809 colorectal, and 116,232 lung cancer patients. Individuals with IDD experienced significantly worse survival than those without IDD. The adjusted hazard ratios of all-cause death were 2.74 (95% CI 2.41‒3.12), 2.42 (95% CI 2.18‒2.68), and 1.49 (95% CI 1.34‒1.66) times higher for breast, colorectal, and lung cancer patients with IDD relative to those without. These findings were consistent for cancer-specific deaths. With few exceptions, worse survival for people with IDD persisted regardless of stage at diagnosis.
Conclusion: People with IDD experienced worse cancer survival than those without IDD. Identifying and intervening on the factors and structures responsible for survival disparities is imperative.
期刊介绍:
The Canadian Journal of Public Health is dedicated to fostering excellence in public health research, scholarship, policy and practice. The aim of the Journal is to advance public health research and practice in Canada and around the world, thus contributing to the improvement of the health of populations and the reduction of health inequalities.
CJPH publishes original research and scholarly articles submitted in either English or French that are relevant to population and public health.
CJPH is an independent, peer-reviewed journal owned by the Canadian Public Health Association and published by Springer.
Énoncé de mission
La Revue canadienne de santé publique se consacre à promouvoir l’excellence dans la recherche, les travaux d’érudition, les politiques et les pratiques de santé publique. Son but est de faire progresser la recherche et les pratiques de santé publique au Canada et dans le monde, contribuant ainsi à l’amélioration de la santé des populations et à la réduction des inégalités de santé.
La RCSP publie des articles savants et des travaux inédits, soumis en anglais ou en français, qui sont d’intérêt pour la santé publique et des populations.
La RCSP est une revue indépendante avec comité de lecture, propriété de l’Association canadienne de santé publique et publiée par Springer.